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Abstract
Background: Pancreatic islets of Langerhans originate from endocrine progenitors within the
pancreatic ductal epithelium. Concomitant with differentiation of these progenitors into hormone-
producing cells such cells delaminate, aggregate and migrate away from the ductal epithelium. The
cellular and molecular mechanisms regulating islet cell delamination and cell migration are poorly
understood. Extensive biochemical and cell biological studies using cultured cells demonstrated
that Rac1, a member of the Rho family of small GTPases, acts as a key regulator of cell migration.
Results: To address the functional role of Rac1 in islet morphogenesis, we generated transgenic
mice expressing dominant negative Rac1 under regulation of the Rat Insulin Promoter. Blocking
Rac1 function in beta cells inhibited their migration away from the ductal epithelium in vivo.
Consistently, transgenic islet cell spreading was compromised in vitro. We also show that the EGF-
receptor ligand betacellulin induced actin remodelling and cell spreading in wild-type islets, but not
in transgenic islets. Finally, we demonstrate that cell-cell contact E-cadherin increased as a
consequence of blocking Rac1 activity.
Conclusion: Our data support a model where Rac1 signalling controls islet cell migration by
modulating E-cadherin-mediated cell-cell adhesion. Furthermore, in vitro experiments show that
betacellulin stimulated islet cell spreading and actin remodelling is compromised in transgenic islets,
suggesting that betacellulin may act as a regulator of Rac1 activity and islet migration in vivo. Our
results further emphasize Rac1 as a key regulator of cell migration and cell adhesion during tissue
and organ morphogenesis.
Background
All three major pancreatic cell types, including acinar,
ductal and endocrine cells, originate from common Insu-
lin promoter factor (Ipf1)/Pancreatic and duodenal
homeobox 1 (Pdx1) -expressing progenitors within the
posterior foregut endoderm. Initially, these cells evaginate
from the foregut endoderm to form the dorsal and ventral
pancreatic buds that later fuse to form the proper pan-
creas. The pancreatic epithelium proliferates and branches
into the surrounding mesenchyme to form a highly
branched epithelial sheet [1,2]. Concomitant with
branching morphogenesis, cells of the pancreatic ductal
epithelium differentiate into Neurogenin 3 (Ngn3)-
expressing endocrine precursors through regulation of
Notch signalling [3,4]. During the secondary transition
which starts around embryonic day (E)13, these Ngn3-
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positive progenitors differentiate into hormone-produc-
ing islet cells which delaminate and migrate out into the
surrounding mesenchyme to initiate clustering into vascu-
larised islets of Langerhans, consisting of the α-, β-, ε-, δ-
and PP-cells [5,6].
Although morphological evidence for delamination of
endocrine cells from ducts was first shown by Pictet and
Rutter [6], the cellular and molecular mechanisms under-
lying the delamination and migration processes are
poorly understood. Regarding the potential mechanisms
for delamination, it has been proposed that it may involve
breaking down the basal lamina, e.g. through the activity
of matrix metalloproteinases (MMPs) [7]. This hypothesis
was tested by analysing mice deficient for MMP2 and
MMP9 or overexpressing TIMP1, an inhibitor of MMPs,
during pancreas development. However neither endo-
crine cell delamination nor islet cell migration was
effected in these mice [8]. In fact, these results are consist-
ent with electron micrographs [6] which provide morpho-
logical evidence for cells not breaking through the basal
lamina during delamination, but rather budding off with
a piece of the basal lamina intact around the delaminating
endocrine cells. Thus, other processes are likely to be
responsible for islet cell delamination during islet mor-
phogenesis. Insights into the potential mechanisms for
islet cell migration have been contributed by gene abla-
tion studies demonstrating that Wnt5a and the epidermal
growth factor (EGF)-receptor are required for migration of
newly formed β cells from the ductal epithelium [9,10].
However, the mechanism of action remains unknown.
Furthermore, the fact that these mice succumb to other
severe phenotypes shortly after birth, suggests that it can-
not be excluded that the pancreas phenotype is secondary
to other phenotypes.
Cell migration requires dynamic regulation of cell-cell
and cell-extracellular matrix (ECM) adhesion, as well as of
cytoskeletal rearrangement. Pioneering work highlight
Rho-GTPases as key regulators of actin cytoskeleton
dynamics and lamellipodia formation [11,12]. The Rho
family of small GTPases act as molecular switches, cycling
between an active GTP-bound and an inactive GDP-
bound state [13]. Numerous reports have demonstrated
an active role of the Rho-GTPase member Rac1 in cell
migration and cell-cell adhesion in cultured cells [14-16].
Rac1 is ubiquitously expressed in vivo [17] and Rac1 null
mutant mice show severe developmental defects, includ-
ing failure to form the three germ layers during gastrula-
tion [18], precluding studies of its role in later processes
such as organogenesis. In Drosophila, Rac1 regulates both
tubulogenesis and dorsal closure [19-21], suggesting an
important in vivo role of Rac1 in both cell migration and
cell-cell adhesion. Notably, a common denominator
when Rac1 function is perturbed is consequences on E-
cadherin-mediated cell-cell adhesion [15]. However,
inconsistent results, such as Rac1 being capable of both
promoting and inhibiting E-cadherin mediated cell-cell
adhesion, make it difficult to extract a clear picture of how
Rac1 regulates E-cadherin function in vivo [22,23].
To shed more light on the in vivo function of Rac1 as a reg-
ulator of cell-cell adhesion and cell migration during tis-
sue formation and organogenesis, we have addressed its
role in pancreatic islet morphogenesis. For this purpose,
transgenic mice were generated where a dominant nega-
tive form of Rac1 (RacN17) was expressed under regula-
tion of the Rat Insulin Promoter (RIP-RacN17). RacN17
has been extensively used to study Rac1 function both in
vitro and in vivo (reviewed by [14,16]). RacN17 has a low
affinity for GTP and thereby remains in its inactive GDP
bound state. By binding to upstream activating exchange
factors (GEFs) it is believed to prevent these factors from
activating endogenous Rac1 [24].
We identify Rac1 as a key signalling molecule regulating
migration of endocrine cells away from the ductal epithe-
lium. Changes in the expression and levels of cell-cell con-
tact E-cadherin, suggest that the mechanism of action may
involve control of E-cadherin-mediated cell-cell adhesion.
Furthermore, in vitro experiments show that betacellulin
stimulated islet cell spreading and actin remodelling is
compromised in transgenic islets, suggesting that betacel-
lulin may act as a regulator of Rac1 activity and islet
migration in vivo.
Results
Previously, it was demonstrated that Rac1 mRNA is
expressed in the pancreas [17]. Here we show that in the
developing pancreas Rac1 mRNA is ubiquitously
expressed in all major pancreatic cell types, including duc-
tal, acinar, endocrine and mesenchymal cells at E15.5 and
postnatal day (P) 3 (Fig. 1). Notably, the most terminal
parts of the ductal tree, including acinar cells, express the
highest level of Rac1 mRNA (Fig. 1A,C). Results from
microarray analysis of E15.5 embryonic pancreas suggest
that the closely related Rac2 and Rac3 are expressed to a
much lower extent (<5% of Rac1 expression) (data not
shown). We speculate that these low levels of Rac2 and
Rac3 mRNAs most likely represent either very low level
expression within the epithelium or normal expression
within haematopoetic cells [25].
To investigate the role of Rac1 in islet morphogenesis, a
transgenic mouse model was generated where a C-myc-
tagged dominant-negative form of the Rac1 protein was
expressed under regulation of the rat insulin promoter
[26] (Fig. 2A). Three independent transgenic lines, con-
firmed by Southern blot analysis (data not shown),
expressing comparable levels of the transgene were identi-BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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fied. RacN17 was found to be expressed on average at
approximately four fold higher levels compared to endog-
enous Rac1 (Fig. 2B–C, and data not shown). Because all
three lines showed the same phenotype, the presented
data is from one line. Control experiments demonstrated
that expression of the transgene was restricted to insulin-
producing cells both in embryos (E17.5) and adults, and
that the expression levels of the transgene varied between
individual cells within the islets (Fig. 2D–L). We observed
no difference in body weight, pancreas weight or fasting
Expression of Rac1 mRNA in embryonic and neonatal pancreas Figure 1
Expression of Rac1 mRNA in embryonic and neonatal pancreas. Rac1 mRNA expression was analysed by in situ 
hybridization. Rac1 mRNA is expressed in ducts (d), acinar (a) and endocrine (e) cells in the pancreas both in the developing 
embryo (E15.5) (A) and in the neonatal pancreas (P3) (C). The levels of Rac1 are highest in the acinar cells. (B,D) Sense probes 
showing background staining. Bars, 100 μm.BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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blood glucose levels between wild-type and transgenic lit-
termates (Fig. 3A–C).
Blocking Rac1 function results in impaired migration of 
islet cells
Numerous studies have demonstrated an active role of
Rac1 in cell migration (reviewed in [16]). Careful analysis
of pancreas development in RIP-RacN17 mice revealed no
defects preceding islet morphogenesis, the ductal epithe-
lium showed normal branching and differentiation (data
not shown). Whereas delamination of newly differenti-
ated β cells and subsequent clustering into vascularised
islet-like structures proceeded normally, movement of
islets away from ducts was perturbed. The latter was evi-
dent from the observation that islets were consistently
found more closely associated with ducts compared to
wild-type littermates (Fig. 4). Since almost all islets are to
some extent in contact with a duct in the neonatal pan-
creas this phenotype was quantified by estimating the per-
centage of the islet circumference in contact with a duct at
P3, demonstrating a significant increase in islet-duct con-
tact in transgenic mice compared to wild-type littermates
(Fig. 4A,C,E). Further analysis showed that this phenotype
persisted in the adult (Fig. 4B,D,F). In support of this find-
ing was the observation that mild collagenase-perfusion
resulted in a significantly higher number of transgenic
islets attached to ducts compared to wild-type islets – a
phenotype that could be attributed to stronger islet-ECM
interactions (Additional file 1). Importantly, control
experiments showed that this phenotype was not second-
ary to an increased ductal area, i.e. the duct/pancreas ratio
was the same in wild-type and RIP-RacN17 mice (Fig.
3D). Furthermore, no changes in β cell area, or endocrine
cell ratios were observed (Fig. 3E–H). Finally, careful
examination of the final islet morphology and shape
revealed more irregularly shaped large islets in RIP-
RacN17 mice compared to wild-type littermates (Addi-
tional file 2), whereas small and medium sized islets
exhibited a normal shape. Altogether, these findings sug-
gest a functional role of Rac1 in islet cell migration and
morphogenesis.
Islet cell spreading in vitro depends on Rac1 function
To further study the role of Rac1 in islet cell migration,
attempts were made to develop an in vitro islet cell migra-
tion assay. For this purpose, islets were dissociated into
single cells and seeded onto gelatin-coated plates. How-
ever, neither wild-type nor transgenic cells showed any
characteristic signs of migratory cells, such as lamellipodia
and active remodelling of the actin cytoskeleton, render-
ing this method unfeasible for comparative studies of cell
migration in vitro (data not shown). To develop an alter-
native strategy to study islet cell migration in vitro, we con-
sidered the fact that in vivo movement of islets involve
migration of intact islet clusters rather than movement of
Construct design and expression of the RIP-RacN17 trans- gene Figure 2
Construct design and expression of the RIP-RacN17 
transgene. (A) Dominant negative Rac1 (RacN17) was 
inserted in a vector containing the Rat Insulin Promoter 
(RIP). A C-myc-tag (red) fused to the N-terminal end of 
RacN17 enabled monitoring of expression of the transgene. 
Rabbit β globin intron (βgi) and poly A (βgpA) was inserted 
to enhance the expression of the transgene. (B) An immuno-
blot on islets from adult mice demonstrating expression of 
endogenous Rac1 in wild-type (Wt) islets and expression of 
endogenous Rac1 and slightly larger RacN17 in transgenic 
(Tg) islets. (C) Western blot quantification of protein shows 
that RacN17 is expressed at approximately four fold higher 
levels than endogenous Rac1 in isolated adult islets (n = 5). 
(D-L) Immunofluorescence staining on frozen sections with 
antibodies against C-myc (red) and insulin (green) at E17.5 
(D-F) and in the adult (G-I). The transgene is selectively 
expressed in β cells, and the expression levels tend to vary 
within the β cell population, especially in the adult. (J-L) Adult 
wild-type islets show no labelling with C-myc. Error bars rep-
resent standard deviation from the mean (± s.d.). Bars, 50 
μm.BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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Body weight, pancreas weight, fasting blood glucose, ductal area, β cell area and islet cell ratios are unaffected in RIP-RacN17  mice Figure 3
Body weight, pancreas weight, fasting blood glucose, ductal area, β cell area and islet cell ratios are unaffected 
in RIP-RacN17 mice. (A,B) Quantification of body and pancreas weight of six months old female mice showed no difference 
between transgenic and wild-type littermates (n = 3). (C) Fasting blood glucose levels in 7–9 month old mice (7 Wt male + 11 
Tg male) showed no differences between transgenic and wild-type littermates. (D) Measurements of the percentage of pan-
creas area occupied by DBA-labelled ducts on frozen sections of eight to nine weeks old mice showed no difference between 
transgenic and wild-type littermates (n = 4). (E) Quantification of β cell area (Ins Area/Ecad Area) in eight to nine weeks old 
mice showed no difference between transgenic and wild-type littermates (n = 3). (F-H) Measurements of endocrine cell area 
ratios in eight to nine weeks old mice showed no difference between insulin and glucagon (Glu Area/Ins Area) (F), insulin and 
somatostain (Som Area/Ins Area) (G) or insulin and pancreatic polypeptide (PP Area/Ins Area) (H) (n = 3). Error bars repre-
sent standard deviation from the mean (± s.d.).BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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individual islet cells. Therefore, the in vitro behaviour of
isolated wild-type and RIP-RacN17 islets plated on gela-
tin-coated dishes was compared. Normally, islets attach to
the surface and after a few days in culture they start to
plate out on the surface, changing from a three-dimen-
sional to a two-dimensional structure. Interestingly,
although transgenic islets attach to the surface, they plate
out less efficiently compared to wild-type islets (Fig.
5A,B,E). Nonetheless, the transgenic islets that do plate
out show the same type of actin remodelling as seen in the
wild-type (Fig. 5C,D), suggesting that the actin cytoskele-
Blocking Rac1 activation results in impaired migration of β  cells Figure 4
Blocking Rac1 activation results in impaired migra-
tion of β cells. Frozen sections of P3 (A,C) and adult (B,D) 
pancreata were stained with antibodies against the ductal 
marker DBA (red) and insulin (green). The endocrine clus-
ters in the RIP-RacN17 mice (C,D) are found more closely 
associated with the ducts both at P3 and in the adult com-
pared to wild-type (A,B). (E) Quantification of the percentage 
of islet circumference in contact with a duct at P3 shows an 
increase in transgenic mice compared to wild-type litterma-
tes, marking a closer association between islets and ducts in 
transgenic animals (n = 4). (F) Quantification of the distance 
between the islet and its closest duct in the adult pancreata 
shows a reduced distance in the transgenic animals compared 
to wild-type littermates (n = 4). Error bars represent stand-
ard deviation from the mean (± s.d.) and significant values are 
indicated as **p < 0.01 and ***p < 0.0001 determined by Stu-
dent's t-test. Bars, 50 μm.
Blocking Rac1 activation inhibits plating of islets in vitro Figure 5
Blocking Rac1 activation inhibits plating of islets in 
vitro. (A,B) Isolated islets were seeded onto gelatin coated 
tissue culture dishes and incubated for one week. Whereas 
wild-type islets plate out and show actin remodelling; marked 
by phalloidin staining of stress fibres (arrows) of leading-edge 
cells (C), the RIP-RacN17 islets remained intact (B) with 
minor actin remodelling (D). (E) Quantification of the plating-
efficiency of islets after one week in culture showed lower 
plating-efficiency of transgenic islets compared to wild-type 
islets (n = 5). Arrowheads in C and D indicate focal contacts 
and junctional F-actin, respectively. Error bars represent 
standard deviation from the mean (± s.d.) and significant val-
ues are indicated as *p < 0.05 determined by Student's t-test. 
Bars, 100 μm (A,B) and 20 μm (C,D).BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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tal rearrangements normally involved in the basic migra-
tory machinery is not blocked in all islets.
Failure to activate Rac1 results in an accumulation of E-
cadherin in cell-cell contacts of β cells
Cell-cell adhesion is necessary for movement of cells dur-
ing tissue formation and organogenesis. To regulate such
events the on and off state of cell-cell adhesion must be
dynamically regulated. Although cadherin-mediated cell-
cell adhesion is crucial for the initial clustering of islet
cells [27], its contribution to movement of islets during
islet morphogenesis remains unknown. The fact that
numerous reports support a regulatory role of Rac1 in E-
cadherin-mediated cell-cell adhesion (reviewed in [15]),
led us to investigate whether expression of RacN17
affected E-cadherin function. Since isolation of neonatal
islets is not feasible, Western blot analysis cannot be used
to quantify E-cadherin protein abundance. As an alterna-
tive method quantification of E-cadherin staining inten-
sity was used. Indeed, E-cadherin protein was upregulated
in transgenic islets at P3 (Fig. 6A–C), whereas β-catenin
levels appeared unaffected (data not shown). Quantita-
tive reverse transcription real-time PCR on single isolated
adult β cells showed a correlation between E-cadherin and
RacN17 expression, i.e. cells expressing higher levels of
RacN17 expressed higher levels of E-cadherin (Fig. 6D),
suggesting that Rac1 inhibition stimulates E-cadherin tran-
scription and/or E-cadherin mRNA stability. Importantly,
Rac1 does not seem to exhibit a general effect on cad-
herin-mediated cell-cell adhesion since no/weak correla-
tion was observed between N-cadherin and transgene
mRNAs (Fig. 6E). R-cadherin is also expressed in islets
[28], but since it is expressed at low levels and distributed
mainly intracellularly (Dahl and Semb, unpublished) it is
not considered to contribute to islet cell adhesion.
Expression and localisation of ECM components remain 
unaltered in RIP-RacN17 mice
Not only does cell migration require appropriate dynam-
ics of cell-cell interactions, but also precise regulation of
attachment and de-attachment to the surrounding ECM.
The latter may also require proteolytic cleavage of the
basal lamina ECM to get access to the surrounding ECM
that function as a substratum for cell migration. To inves-
tigate whether the impaired migration of the islets away
from the pancreatic ducts in RIP-RacN17 mice could be
explained by an excessive deposition of ECM around the
islets which would physically prevent movement of the
islets, the distribution of various islet ECM components
were examined. Consistent with the demonstration that
islet ECM is mainly produced by blood vessels, which are
recruited to islets during islet morphogenesis [29], no
change in the deposition of laminin, collagen IV, and
fibronectin were observed (Additional file 3A–F). Alterna-
tively, deficient cell migration could be explained by com-
promised expression/activity of ECM-receptors such as
integrins. However, no change in expression pattern or
activity of the major islet integrin-receptor integrin β1 or
the adaptor, vinculin, was observed (Additional file 3G–
Deficient activation of Rac1 in β cells correlates with charac- teristic signs of enhanced cell-cell adhesion Figure 6
Deficient activation of Rac1 in β cells correlates with 
characteristic signs of enhanced cell-cell adhesion. 
(A,B) Immunofluorescence staining on frozen sections of P3 
pancreata with antibodies against E-cadherin. E-cadherin lev-
els are higher in transgenic (B) compared to wild-type (A) 
islets. Islets are indicated by dotted lines. (C) Quantification 
of E-cadherin average staining intensity in P3 mice shows an 
increase in islet E-cadherin intensity relative to the levels in 
surrounding acinar tissue in transgenic compared to wild-
type pancreata (n = 4). (D,E) Quantitative reverse transcrip-
tion real-time PCR on single isolated adult β cells shows that 
E-cadherin but not N-cadherin mRNA correlates with 
RacN17 mRNA (Values presented as log2 ratios). Ecad-Rac1 
shows a Pearson coefficient of 0.70 (if outlier is excluded) 
(D), whereas Ncad-Rac1 shows a Pearson coefficient of 0.44 
(E). Error bars represent standard deviation from the mean 
(± s.d.) and significant values are indicated as **p < 0.01 
determined by Student's t-test. Bars, 50 μm.BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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L). In conclusion, these results demonstrate that Rac1
affects islet cell-cell adhesion but appears not to affect
expression/distribution of the analysed ECM compo-
nents.
Rac1 regulates betacellulin-induced spreading of islets in 
vitro
To identify the signalling pathway that regulates islet
migration through Rac1, two previous observations were
of particular interest. First, deficient migration of islets
away from ducts was observed in EGF-receptor-deficient
mice [10]. Secondly, Rac1 activity has previously been
shown to be dependent on EGF-receptor stimulation in
other cell types [30]. To investigate whether Rac1 is a
downstream signalling component of the EGF-receptor
during islet cell migration, isolated islets were cultured in
the presence or absence of the EGF-receptor ligand beta-
cellulin. Interestingly, betacellulin stimulated plating of
wild-type islets (Fig. 7). Consistent with Rac1 acting
downstream of the betacellulin/EGF receptor complex,
betacellulin's stimulatory activity on islet plating was
blocked in RIP-RacN17 islets. These results suggest that
Rac1 acts downstream of the EGF-receptor during betacel-
lulin-induced islet cell spreading.
Discussion
Although much is known about the cellular and molecu-
lar processes that are controlled by members of the Rho-
GTPases, there is still a gap in the knowledge of their extra-
cellular effectors and their in vivo function during tissue
and organ formation, in particular in mammalian organ-
isms. In the developing pancreas, islet morphogenesis,
including endocrine cell delamination from ducts and
islet cell migration, has not been resolved at a cellular and
molecular resolution. The fact that these events most
likely involve cellular processes that have been reported to
be coordinated by Rac1, such as cell migration and cell
adhesion [31], led us to study the functional role of Rac1
in islet morphogenesis. For this purpose, a dominant neg-
ative form of Rac1 was expressed in β cells. We show that
blocking Rac1 activity in β cells results in compromised
migration of islets away from ducts. In fact, more islets
remain in direct contact with ducts. The result can neither
be explained by a general developmental delay, nor by an
increase in the area of the ductal network. Furthermore,
we provide evidence that the function of Rac1 in islet cell
migration may be controlled by modulation of E-cad-
herin-mediated cell-cell adhesion. Compromised islet cell
migration does not result in a major impact on islet cell
function, since fasting glucose levels remained unaltered.
The conclusion that Rac1 is involved in islet cell migration
is based on both in vivo and in vitro observations. In vivo,
islet cells normally migrate away from ducts subsequent
to delamination and clustering. Blocking Rac1 function
resulted in deficient migration away from ducts. To study
the migration in more detail we used an in vitro model
where isolated islets were seeded onto gelatin-coated cul-
ture dishes. Normally, islets attach and eventually flatten
out due to induced cell spreading. Cell spreading is asso-
ciated with increased formation of cell-ECM interactions
(focal contacts) and actin remodelling by leading edge
cells. However, blocking Rac1 function in β cells resulted
in reduced islet cell spreading. Altogether, the in vivo and
in vitro results suggest that Rac1 is directly involved in the
migration of islets and that the underlying mechanism
may involve regulation of cell-ECM interactions, cell-cell
adhesion, and rearrangement of the actin cytoskeleton.
The in vitro studies show that betacellulin stimulated islet
cell spreading and actin remodelling is compromised in
transgenic islets, suggesting that betacellulin may act as a
regulator of Rac1 activity and islet migration in vivo.
Rac1 has previously been shown to regulate E-cadherin-
mediated cell-cell adhesion. However, the picture is rather
complex since Rac1 has been reported to both promote
and inhibit E-cadherin function. For example, E-cadherin
activity is regulated by endocytosis, and Rac1 has been
demonstrated to both promote and block E-cadherin
endocytosis [22,23]. To explain such contradictory results,
it has been speculated that the effect of Rac1 on E-cad-
herin endocytosis may depend on different downstream
Betacellulin-stimulated plating of islets is blocked when Rac1  function is inhibited Figure 7
Betacellulin-stimulated plating of islets is blocked 
when Rac1 function is inhibited. Isolated islets were 
grown in 5% FCS for two days before switched to 0.5% FCS 
with and without betacellulin (25 ng/ml) (Day 1). Whereas 
betacellulin stimulated plating of wild-type islets (on average 
four days to surpass 15% plating-efficiency compared to six 
days for unstimulated islets, p < 0.05 in a Student's t-test (n = 
6)), plating of RIP-RacN17 islets were unaffected (n = 5). 
Error bars represent standard error of the mean (s.e.m).BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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effectors due to the cellular context [31]. Here, we provide
evidence in support of Rac1 controlling E-cadherin func-
tion during pancreatic islet morphogenesis by demon-
strating that blocking Rac1 function in β cells results in
increased levels of E-cadherin mRNA and protein.
Increased levels of E-cadherin at cell-cell contacts may cre-
ate a more static cell-cell adhesion, which may inhibit the
cell movement/rearrangement needed for islets cells to
spread in vitro as well as for their in vivo migration away
from ducts. Consistently, recent data demonstrate that the
consequence of blocking Rac1 function (either through
loss of function mutations or by a dominant negative
approach) during Drosophila tubulogenesis, results in
perturbed cell rearrangement due to increased E-cadherin
protein expression [19,20]. The observed increase of cell-
cell contact E-cadherin may also explain the irregular
shape of the largest islets in RIP-RacN17 mice. Normally,
islets form by fusion of the initial endocrine cell clusters
that appear soon after delamination [32]. In order to form
the final shape of the mature islet, dynamic cellular rear-
rangements between neighbouring cells are necessary.
Such processes most likely require dynamic changes in
cell-cell adhesion and remodelling of the actin cytoskele-
ton. The existence of large islets with an irregular shape in
transgenic mice could either be explained by a failure of
smaller islets to separate from each other or by perturbed
cellular rearrangement in the largest islets. Altogether, our
results support the concept that islet migration away from
ducts depend on Rac1-mediated regulation of E-cadherin
cell-cell adhesion and actin cytoskeletal remodelling.
It has been suggested that migration of endocrine cells
away from the ductal epithelium requires degradation of
the basal lamina by MMPs [7]. However, gene ablation
studies of MMPs in the developing pancreas showed no
effect on islet formation [8]. These results indicate that
degradation of the ECM is not necessary for islet migra-
tion, suggesting that Rac1's role in islet migration does not
involve proteolytic cleavage of ECM components. Further-
more, this conclusion is consistent with the observation
that the deposition of basal lamina components, such as
laminin and collagen IV, as well as fibronectin was unaf-
fected upon Rac1 inhibition.
To identify in which signalling pathway Rac1 acts as an
effector for islet cell migration, we considered the previ-
ous findings that EGF-receptor gene ablation results in a
similar phenotype with increased association of islets
with ducts [10] and that EGF-receptor signalling regulates
Rac1 activity [30,33-35]. To establish a potential link
between Rac1 and EGF-receptor signalling during islet
migration, we tested the activity of the EGF-receptor lig-
and betacellulin on wild-type and RIP-RacN17 islet cell
spreading in vitro. These experiments showed that betacel-
lulin stimulates islet cell spreading. The fact that betacel-
lulin was unable to promote spreading of transgenic islets
suggests that Rac1 acts as a downstream component in the
betacellulin/EGF-receptor signalling pathway during islet
cell spreading. Apart from the EGF-receptor (erbB-1) beta-
cellulin also binds to erbB-4. However the fact that the
expression of erbB-4 in neonatal and adult pancreas is
restricted to ductal- and α-cells [36], suggests that betacel-
lulin signals through erbB-1. Based on these results, we
propose a model for islet cell migration where betacellu-
lin/EGF-receptor signalling controls the activity of Rac1,
which coordinates changes in E-cadherin-mediated cell-
cell adhesion and actin rearrangements to facilitate islet
cell movement. This model predicts that the reported defi-
cient migration of islets in EGF-receptor-deficient mice is
at least in part due to compromised Rac1 activation.
RacN17 may affect other GTPases [37], thus expression of
RacN17 could in theory inhibit other Rac members, such
as Rac2 and Rac3. However, Rac2 and Rac3 are not
expressed in the pancreas [25,38]. Moreover, RacN17
could affect other Rho-GTPases, such as Cdc42. However,
analysis of pancreas specific ablation of Cdc42 shows that
the RIP-RacN17 phenotype cannot be attributed to block-
ing Cdc42 activity (Kesavan and Semb; unpublished).
Thus, although we cannot rule out that RacN17 may affect
other GTPases in β cells, we believe that the phenotype
observed in RIP-RacN17 mice primarily involves Rac1.
Our model predicts a potential link between EGF-receptor
signalling and E-cadherin function via Rac1 in β cells.
How does Rac1 control the levels of E-cadherin protein in
pancreatic β cell-cell contacts? To this end we provide evi-
dence in support of Rac1 controlling E-cadherin transcrip-
tion and/or mRNA stability. Post-translational effects may
also be operational because a recent study showed that
EGF induces macropinocytosis of E-cadherin through
Rac1 activation [33]. Based on such findings, we speculate
that inhibiting Rac1 could block EGF-induced recycling of
E-cadherin, resulting in an accumulation of E-cadherin at
the cell surface, thereby creating a more static "on-state" of
cell-cell adhesion. Consequently, the mechanism by
which betacellulin induces migration of islets through
Rac1 could tentatively be explained by an effect on E-cad-
herin recycling – a question to be resolved by future stud-
ies.
Conclusion
In summary, our results provide new insight into how
Rac1 controls organogenesis. Specifically, our data sup-
port a model where Rac1 signalling controls islet cell
migration by modulating E-cadherin-mediated cell-cell
adhesion. Furthermore, in vitro experiments show that
betacellulin stimulates cell spreading and actin remodel-BMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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ling in wild-type but not transgenic islets, suggesting that
betacellulin may act as a regulator of Rac1 activity and
islet migration in vivo. Our results further emphasize Rac1
as a key regulator of cell migration and cell adhesion dur-
ing tissue and organ morphogenesis.
Methods
Generation of transgenic mice
A cDNA with a C-myc-tagged RacN17 [39] was inserted in
to a vector containing 0.7 kb of the Rat Insulin Promoter
[26] and the rabbit β globin intron and polyA sequences.
The construct was cut out by enzymatic digestion and
purified before pronuclear injection. Transgenic mice
were obtained by pronuclear injection at the Karolinska
Center for Transgene Technologies. Founders were con-
firmed with PCR and Southern Blot. Mice were back-
crossed against C57Bl/6J background and wild-type
littermates were used as controls. Analysis of three indi-
vidual founder strains showed that all three strains exhib-
ited the same phenotype. Genotyping was performed by
standard PCR-methods using the primers MycMut2, 5'-
AGAAGCTGATCTCCGAGGAG-3', and hRac-Rev1, 5'-
GAATAATTGTCAAAGACAGTAG-3'. The expression of the
transgene was also confirmed by immunohistochemsitry.
Animals were maintained in an approved animal facility
and all animal work was carried out in accordance with
approval by the local ethics committee for animal
research.
Weight and fasting blood glucose level measurements
Female transgenic RIP-RacN17 mice and wild-type litter-
mate controls, six months of age were weighed and pan-
creas was carefully dissected out before weight
measurement. For fasting blood glucose level measure-
ments, male transgenic RIP-RacN17 mice and wild-type
littermate controls of seven to nine months were fasted
overnight. Blood was obtained from the tail vein and glu-
cose levels were measured using a glucometer.
In situ hybridization
A probe against the 3' end of Rac1 was used (a kind gift
from Dr Ivan de Curtis) and was performed as previously
described [38]. Briefly, P3 and E15.5 pancreata were fixed
in PBS-4% PFA, embedded in Tissue-Tek®  O.C.T.™
(Sakura) and 10 μm sections were mounted onto Super-
frost© Plus slides (Menzel). Digoxigenin labelling of anti-
sense and sense strand was performed with T3 and T7
RNA polymerase-mediated transcription respectively
according to the manufacturers instructions (Roche).
Overnight hybridization was carried out with 1 μg/ml of
the probe in a solution consisting of 50% deionized for-
mamide, 1 × Denhardt's solution, 10% dextran sulfate,
0.5 mg/ml tRNA and 3 × SSC at 60°C.
Immunohistochemistry and immunoreagents
For immunohistochemistry, tissues were fixed in PBS-4%
PFA overnight at 4°C. For cryo sections, tissues were incu-
bated in PBS-30% sucrose overnight at 4°C, embedded in
Tissue-Tek® O.C.T.™ (Sakura) and 10 μm thick sections
were mounted on poly lysine coated slides. Sections were
blocked in PBS-0.1% Triton X-100 containing 5% non fat
dry milk for one hour before incubating with primary
antibodies overnight in blocking solution. Slides were
incubated with secondary antibodies diluted in blocking
solution for one hour before washing and mounting.
Immunoreagents used were DBA (1:1000; Vector Labora-
tories), guinea pig anti-insulin (1:800; Dako), rabbit anti
somatostatin (1:500; Sigma), rabbit anti glucagon
(1:2000; Linco Research), rabbit anti pancreatic polypep-
tide (1:200; Euro Diagnostica), DAPI (1:1000; Molecular
Probes), rat anti-E-cadherin ECCD-2 (1:300; [40]), mouse
anti-C-myc 9E10 (1:200; [41]), rabbit anti-laminin
(1:500; Sigma), mouse anti-collagen IV (1:200; Hybrid-
oma bank), rabbit anti-fibronectin (1:300; Dako), mouse
anti-vinculin (1:100; Sigma), rat anti-integrin β1 (1:500;
Chemicon), rat anti-integrin β1 (active form) (1:750; BD
Pharmigen), Alexa Fluor® 488 phalloidin (1:500; Invitro-
gen). Stained sections were photographed in an Axiopla-
nII fluorescent microscope and analysed using Axiovision
LE software (Zeiss). Secondary antibodies used included
Cy3 anti -rabbit, -rat, -mouse and -streptavidin (Jackson
Immuno Research), Alexa Fluor®  488 anti-guinea pig
(Molecular Probes) and TRITC anti-mouse IgG1 (South-
ern Biotech).
Immunoblotting
Islets were boiled for five minutes in Sample Buffer (100
mM TRIS, 4% (w/v) SDS, 0.2% (w/v) bromophenol blue,
20% (w/v) glycerol, 200 mM β-mercaptoethanol), centri-
fuged for five minutes at 5900 G and samples were sepa-
rated on SDS-PAGE before transferred onto a
nitrocellulose filter (Amersham). The filter was blocked
for two hours in PBS-0.05% Tween-20 containing 3% BSA
and blotted with mouse anti-Rac1 primary antibody
(1:1000; Upstate) overnight at 4°C in blocking solution.
The blot was incubated with HRP-conjugated anti mouse
secondary antibody (Sigma) for one hour and proteins
were visualized by chemiluminescence (Amersham).
Quantification of transgenic expression was performed by
measuring the ratio of the band intensity on blots
between RacN17 and endogenous Rac1 using Image
Gauge (Fuji).
Isolation and plating of islets
Islets and islet cells were isolated according to Olofsson et
al. [42]. Briefly, pancreas from sex matched transgenic
mice and wild-type littermates two to six months old wereBMC Developmental Biology 2009, 9:2 http://www.biomedcentral.com/1471-213X/9/2
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perfused with Collagenase P (1.8 U/ml) (Roche) in HBSS,
and incubated at 37°C for 20 minutes. For the mild Col-
lagenase P treatment we used a lower concentration of the
enzyme (0.57 U/ml). The tissue was dispersed by manual
shaking and islets were picked manually. To obtain single
cells, isolated islets were incubated in Calcium free media
(138 mM NaCl, 5.6 mM KCl, 1.2 mM MgCl2, 5 mM
HEPES, 3 mM Glucose, 1 mM EGTA 0.1% (w/v) BSA, pH
7.4) at 37°C for 12 minutes and islets were dissociated by
pipetting. The cells were washed in HBSS before further
usage. Isolated islets were plated onto gelatin coated tissue
culture dishes and cultured for seven days in RPMI1640
(Invitrogen) supplemented with 10% FCS. The number of
plated islets was determined by daily inspection of the
cultures.
For the treatment with the EGF-receptor ligand betacellu-
lin (R&D systems), the islets from each animal were
divided into two wells to recover in RPMI with 5% FCS for
48 hours, after which islets were incubated in RPMI with
0.5% FCS with or without 25 ng/ml of betacellulin.
Quantitative single cell analysis
Gene expression analysis in individual β cells using quan-
titative reverse transcription real-time PCR was performed
as previously described [43]. Individual cells were col-
lected with a glass patch-clamp pipette using a hydraulic
micromanipulator. Pipettes were emptied in lysis buffer
containing 50 mM Tris-HCl (pH 8.0), 140 mM NaCl, 1.5
mM MgCl2, and 0.5% Igepal CA-630. Samples were
heated to 75°C followed by vortexing. Tubes were then
immediately frozen with dry ice until storage in -20°C.
SuperScript III (Invitrogen) was used to generate cDNA
using oligo dT and random hexamers as primers accord-
ing to the manufacturer's instructions. Real-time PCR was
measured in the LightCycler (Roche Diagnostics) or the
ABI PRISM 7900 (Applied Biosystems) using SYBR Green
I (Molecular Probes) as detection chemistry. The correct
PCR product was confirmed by melting curve analysis and
agarose gel electrophoresis (2% w/v). The primers used
were MycMut2; hRacRev1; Ecad forward, 5'-CGCTGA-
GATGGACAGAGAAG-3'; reverse, 5'-TCTGCTTTGGCTTC-
CCATCC-3'; Ncad forward, 5'-
CAGGTTTGGAATGGGTCTGT-3'; reverse, 5'-ATGTT-
GGGTGAAGGTGTGCT-3'; Ins II forward, 5'-CCCTGCT-
GGCCCTGCTCTT-3'; reverse, 5'-
AGGTCTGAAGGTCACCTGCT-3'. Ins II was used as a pos-
itive control for β cells, and cells not expressing Ins II were
excluded from the analysis.
Morphometric analysis
β cell area was determined by measuring the percentage of
the E-cadherin positive pancreas area that is insulin posi-
tive on frozen sections separated by 300 μm through the
entire pancreas. Animals were between eight and nine
weeks of age and transgenic and wild-type littermate pairs
of the same sex were used. Endocrine cell ratios was deter-
mined by quantifying the ratio of the area occupied by
glucagon, somatostatin or pancreatic polypeptide com-
pared to the insulin area on ten islet profiles each from the
head and tail of pancreata from eight to nine weeks old
mice on frozen sections.
Measurement of the contact between insulin positive
islets and DBA positive ducts was used to estimate islet/
duct association at P3. To measure the contact between
islets and ducts the percentage of the circumference of
insulin positive islets in contact with a DBA positive duct
on sections was estimated. In total, 50 islets per pancreas
were analysed on stained sections separated by 200 μm.
Duct distance was estimated by measuring the distance
between the islet border, marked by insulin expression
and the closest duct, determined by DBA staining and
the presence of a lumen. Pancreas from eight to nine
weeks old mice were used and 60 islets per pancreas were
measured. Sections were separated by 200 μm. Duct area
was examined by measuring the percentage of the pan-
creas area occupied by DBA labelled ductal epithelium
on 30 20× images per animal. E-cadherin levels in islets
were determined by measuring the average staining
intensity of the pixels in the islet relative to acinar cells
surrounding the islet on images of 10 μm thick frozen
sections. Four regions of acinar cells per islet were meas-
ured and six islets per animal were analysed (n = 4). Islet
shape was determined by calculating the circularity ratio
of 110 islets per animal, marked by a continuous insulin
stained area [44]. Briefly, the area (A) of the islet is
related to its perimeter (p) in the formula 4πA/p2, which
gives a value of one for a perfect circle and the value
decreases as the perimeter increases relative to the area
indicating an irregular shape of the measured object. The
values from the largest ten percent, i.e. the 11 largest
islets per animal are presented in the results. Apart from
duct association at P3 where ImageJ software was used,
all analysis was performed using Axiovision software
(Zeiss).
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Additional file 1
RIP-RacN17 islets attach to ducts after mild collagenase P perfusion. 
(A) Mild collagenase P perfusion of adult pancreata resulted in an 
increased presence of islet-duct aggregates in RIP-RacN17. (B) Quantifi-
cation of islets that were attached to ducts in adult mice after mild colla-
genase P perfusion was determined and shows a statistical significant 
increase in the transgenic animals (n = 4). Error bars represent standard 
deviation from the mean (± s.d.) and significant values are indicated as 
**p < 0.01 determined by Student's t-test (n = 4). Bar, 500 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-2-S1.tiff]
Additional file 2
Deficient activation of Rac1 results in alteration of the shape of large 
islets. (A,B) Paraffin sections from adult mice stained with H&E. Wild-
type islets (A) show a round or oval shape, whereas transgenic islets 
exhibit a more irregular shape. (C) Quantification of the shape of the 
10% largest islets shows a statistical difference between the wild-type and 
the transgene. The circularity ratio (4πA/p2) was compared between the 
wild-type and the transgenic islets (n = 3). Error bars represent standard 
deviation from the mean (± s.d.) and significant values are indicated as 
*p < 0.05 determined by Student's t-test (n = 3) (A = area, p = perime-
ter). Bars, 100 μm.
Click here for file
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Additional file 3
Extracellular matrix adhesion and composition remain unaltered in 
RIP-RacN17 islets. Immunofluorescence staining of adult pancreata with 
antibodies against laminin (A,B), collagen IV (C,D), fibronectin (E,F), 
vinculin (G,H), integrin β1 (I,J) and active integrin β1 (K,L). Bars, 50 
μm.
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